Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 644

1.

NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis.

Hicks T, Stewart F, Eisinga A.

Open Heart. 2016 Jan 18;3(1):e000279. doi: 10.1136/openhrt-2015-000279. eCollection 2016.

2.

Anticoagulation in Atrial Fibrillation - Current Concepts.

Katritsis DG, Gersh BJ, Camm AJ.

Arrhythm Electrophysiol Rev. 2015 Aug;4(2):100-7. doi: 10.15420/aer.2015.04.02.100.

3.

Warfarin related nephropathy: a case report and review of the literature.

Ng CY, Tan CS, Chin CT, Lim SL, Zhu L, Woo KT, Tan PH.

BMC Nephrol. 2016 Feb 1;17(1):15. doi: 10.1186/s12882-016-0228-4.

4.

Risk of major bleeding at different PT-INR ranges in elderly Japanese patients with non-valvular atrial fibrillation receiving warfarin: a nested case-control study.

Ohgushi A, Ohtani T, Nakayama N, Asai S, Ishii Y, Namiki A, Akazawa M, Echizen H.

J Pharm Health Care Sci. 2016 Jan 11;2:2. doi: 10.1186/s40780-015-0036-1. eCollection 2016.

5.
6.

Predicting Hemorrhagic Transformation of Acute Ischemic Stroke: Prospective Validation of the HeRS Score.

Marsh EB, Llinas RH, Schneider AL, Hillis AE, Lawrence E, Dziedzic P, Gottesman RF.

Medicine (Baltimore). 2016 Jan;95(2):e2430. doi: 10.1097/MD.0000000000002430.

7.

A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation.

Pengo V, Zambon CF, Fogar P, Padoan A, Nante G, Pelloso M, Moz S, Frigo AC, Groppa F, Bozzato D, Tiso E, Gnatta E, Denas G, Padayattil Jose S, Padrini R, Basso D, Plebani M.

PLoS One. 2015 Dec 28;10(12):e0145318. doi: 10.1371/journal.pone.0145318. eCollection 2015.

8.

Abstracts of the 3rd Annual Scientific Meeting Indonesian Heart Rhythm Society, October 23 - 24, 2015.

ASEAN Federation of Cardiology.

ASEAN Heart J. 2015 Dec 13;23:4. eCollection 2015.

9.

Persistence of non-vitamin K antagonist oral anticoagulant use in Japanese patients with atrial fibrillation: A single-center observational study.

Shiga T, Naganuma M, Nagao T, Maruyama K, Suzuki A, Murasaki K, Hagiwara N.

J Arrhythm. 2015 Dec;31(6):339-44. doi: 10.1016/j.joa.2015.04.004. Epub 2015 May 18.

10.

Novel oral anticoagulants for atrial fibrillation.

How CH.

Singapore Med J. 2015 Dec;56(12):657-9. doi: 10.11622/smedj.2015184.

11.

Anticoagulation in Heart Failure: a Review.

Zeitler EP, Eapen ZJ.

J Atr Fibrillation. 2015 May 1;8(1):31-38.

12.

Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis.

Namba S, Yamaoka-Tojo M, Hashikata T, Ikeda Y, Kitasato L, Hashimoto T, Shimohama T, Tojo T, Takahira N, Masuda T, Ako J.

BBA Clin. 2015 Aug 12;4:76-80. doi: 10.1016/j.bbacli.2015.08.002. eCollection 2015 Dec.

13.

Primary Care Atrial Fibrillation Service: outcomes from consultant-led anticoagulation assessment clinics in the primary care setting in the UK.

Das M, Panter L, Wynn GJ, Taylor RM, Connor N, Mills JD, Kirchhof P, Gupta D.

BMJ Open. 2015 Dec 9;5(12):e009267. doi: 10.1136/bmjopen-2015-009267.

14.

Global Thrombosis Test - a possible monitoring system for the effects and safety of dabigatran.

Otsui K, Gorog DA, Yamamoto J, Yoshioka T, Iwata S, Suzuki A, Ozawa T, Takei A, Inoue N.

Thromb J. 2015 Dec 8;13:39. doi: 10.1186/s12959-015-0069-6. eCollection 2015.

15.

How to manage warfarin therapy.

Tideman PA, Tirimacco R, St John A, Roberts GW.

Aust Prescr. 2015 Apr;38(2):44-8. Epub 2015 Apr 1. Review.

16.

Transcatheter closure of the left atrial appendage: initial experience with the WATCHMAN device.

Ding J, Zhu J, Lu J, Ding X, Zhang X, Lu W, Ao M, Ma G.

Int J Clin Exp Med. 2015 Sep 15;8(9):15230-7. eCollection 2015.

17.

Clinical utility of dabigatran in United Arab Emirates. A pharmacovigilance study.

Shehab A, Elnour AA, Sadik A, Abu Mandil M, AlShamsi A, Al Suwaidi A, Bhagavathula A, Erkekoglu P, Hamad F, Al Nuaimi SK.

Saudi Med J. 2015 Nov;36(11):1290-8. doi: 10.15537/smj.2015.11.12154.

18.

Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol.

Li G, Holbrook A, Delate T, Witt DM, Levine MA, Thabane L.

BMJ Open. 2015 Nov 5;5(11):e009518. doi: 10.1136/bmjopen-2015-009518.

19.

Extra-pericardial tamponade following Wolf Mini-Maze procedure: a case report.

Bailey JP.

J Cardiothorac Surg. 2015 Nov 5;10:153. doi: 10.1186/s13019-015-0364-0.

20.

An Education Program for Patient Self-Management of Warfarin.

Jenner KM, Simmons BJ, Delate T, Clark NP, Kurz D, Witt DM.

Perm J. 2015 Fall;19(4):33-8. doi: 10.7812/TPP/14-246.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk